Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

TS03 Inc Trust Units TSTIF



GREY:TSTIF - Post by User

Comment by dant2on Feb 22, 2018 1:32pm
144 Views
Post# 27603348

RE:Getinge States They Have Strengthened TSO3 Relationship!!

RE:Getinge States They Have Strengthened TSO3 Relationship!!Very late in coming but I think definately the working relationship is improving. While TOS has been adding staff recently so has Getinge. Within the past 8 weeks or so TOS has had ads for a captial equipment sales person NYC, and a combination of sales and sales support staff in Myrtle Beach, Kansas City, Phoenix and more. They have hired a National Support manager and are looking for additional field service personnel.
Getinge presumably has hired a dedicated VP4 sales person for SFO (ad is now down) and are currently looking for 2 surgical workflow sales people for LA, and these ads specifically cite the VP4 as part of the product portfolio, and this illustrates Getinges' intent to improve asp's and pull through sales.  They have also advertised for US based low temp sterilization service personnel in various locations.
It is a presumption on my part but I assume (and hope) there are specific unit quotas and related compensation incentives (especially) for Getinge sales staff. 
I also noticed two related industry reports with one highlighting robust growth (CAGR ~7.4%) through 2027 for the medical device reprocessing (scopes specifically) , and from this it seems HLD et al is not anticipating and will not be ceding market share easily. The other was for sterilization in the dental market.
In about 4 weeks we will have the Q4 results call and hopefully additional tangible evidence of US market penetration.
I think its 2019 and beyond before AAMI and/or FDA does anything tangible on the regulatory side but we can always hope :)

<< Previous
Bullboard Posts
Next >>